Clinical Trials on Glabellar Furrowing in Australia

Total 7 results

Medy-Tox

Completed

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Glabellar Frown Lines

Australia
Medy-Tox

Completed

Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines

Glabellar Frown Lines

Australia
Ipsen

Completed

Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport® (APPEAL)

Glabellar Lines

Australia, Brazil, Czechia, Kazakhstan, Lebanon, Russian Federation, Turkey, Ukraine
Merz Pharmaceuticals GmbH

Completed

NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines (Head2Head)

Glabellar Frown Lines

United Kingdom, Germany, Austria
Allergan

Completed

Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®

Glabellar Lines

United States, Canada, Brazil, France, Australia
Mayne Pharma International Pty Ltd

Terminated

A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis

Lamellar Ichthyosis

United States, Spain, Canada, Germany, France, Australia, Israel, Ukraine, United Kingdom
Timber Pharmceuticals LLC

Completed

A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis

Congenital Ichthyosis

United States, Australia

3

Subscribe